Indonesian Journal of Clinical Pathology and Medical Laboratory
ISSN 0854-4263
Vol. 16 / No. 1 / Published : 2009-11
Related with : Scholar Yahoo! Bing
Original Article :
Analysis of uric acid level in patients of carcinoma mammae
Author :
- Susi Sevianty*1
- Uleng Bahrun*2
- Mansyur Arif*3
- Departemen Patologi Klinik FK Universitas Hasanuddin – RS Dr. Wahidin Sudirohusodo Makassar
- Departemen Patologi Kinik FK - UNHAS - RS. Dr. Wahidin Sudirohusodo Jl. Perintis Kemerdekaan Km 10 Talamarea Makassar
- Departemen Patologi Kinik FK - UNHAS - RS. Dr. Wahidin Sudirohusodo Jl. Perintis Kemerdekaan Km 10 Talamarea Makassar
Abstract :
In malignancy cases, an increase of uric acid level is often observed after therapy (Tumor Lysis Syndrome), but some studies also indicated an increase before therapy which is related to a refusal reaction against tumor, and specific only for certain malignancy cases. Carsinoma mammae is the second most common malignancy among women in Indonesia, so that studying the phenomenon occurred in carcinoma mammae including uric acid level are expected to provide insight in management of carcinoma mammae. A longitudinal study was conducted by collecting secondary data from medical record of carcinoma mammae patients in Wahidin Sudirohusodo Hospital for period of July 2007–June 2008. Data were analyzed by using Wilcoxon Signed Rank Test with alpha 0.05. 12 of subjects are considered eligible for study criteria, with the age ranging from 28–60 years old. In generally, uric acid level determined before and after chemotherapy showed a level in normal range, except for 3 samples before therapy and 3 different samples after therapy showed a level more than 5.7 mg/dL. Statistic result showed mean uric acid level before chemotherapy was 4.508 ± 1.2566 mg/dL and after chemotherapy was 5.025 ± 1.3240 mg/dL (p = 0.16). Increased of uric acid level is not significant level was found in serum of carcinoma mammae before and after chemotherapy.
Keyword :
References :
Sukardja IDG,(1996) Neoplasia Jakarta : EGC




